ABSTRACT
Background TB treatment success remains low in Uganda at 82%, below the recommended WHO target (≥90%). Consequences of poor treatment outcome include; increased MDR-TB prevalence, treatment costs and death. Kampala Capital City Authority (KCCA) public health facilities are congested which compromises the care given to pulmonary tuberculosis patients (PTB) that affects the treatment success of patients. However, there is scarce information regarding factors that are associated with treatment success among PTB patients in KCCA public health facilities.
General Objective To determine the treatment success and associated factors among patients with pulmonary tuberculosis attending KCCA public health facilities in Kampala between July 2019 and June 2020.
Methods A retrospective cohort study that involved review of records for 772 PTB patients who were enrolled on TB treatment in five KCCA health facilities from July 2019 to June 2020. Data on socio-demographic and clinical factors was abstracted from health facility TB registers. Data was entered in epidata and analyzed using STATA_v14 software. A modified poison regression model with robust standard errors was used in analysis and risk ratios were reported.
Results Treatment success was 87.2% (CI: 84.2%-89.1%), PTB patients who cured accounted for 413 (53.5%) and 260 (33.7%) completed treatment. Factors associated with PTB treatment success were: being classified as a clinically diagnosed PTB patients (aRR= 0.8, CI: 0.53 - 0.94, P value =0.021) and having a positive HIV/AIDS status (aRR= 0.7, CI: 0.43 - 0.88, P value =0.006) reduced treatment success and having a community volunteer as a treatment supporter was associated with increased treatment success (aRR= 1.2, CI: 1.06 - 3.28, P value =0.028).
Conclusion Over 80% of PTB patients in KCCA public health facilities achieve treatment success although this is still below the WHO target. Factors associated with TB treatment success include; being classified as a clinically diagnosed PTB patient, having a positive HIV/AIDS status as factors that reduce treatment success and having a community volunteer as a treatment supporter improves treatment success. Efforts such as consistent follow-ups should be encouraged among clinically diagnosed and HIV/AIDS positive PTB patients. Additionally, community volunteers should be empowered to support PTB patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding from any source was obtained for this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Permission to conduct the study was obtained from Clinical Epidemiology Unit (CEU). Institutional Review Board (IRB) approval to conduct the study was sought from School of Medicine Research and Ethics Committee (SOMREC) under reference number: MAK-SOMREC-2021-182. The researcher sought for waiver of participant consent from SOM-REC since data was abstracted from patient records and thus no direct contact with study participants. Permission was obtained from the Directorate of Public Health and Environment – Kampala Capital City Authority (KCCA). In addition, permission was sought from the facility in-charge(s) for each of the selected health facilities prior to accessing the patient records. Patient identification numbers were used instead of names and the data collected was safely kept under lock and key and on password protected computers with restricted access for only purposes of this research while ensuring confidentiality of all study related data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Authors’ qualifications and contacts: Cathbert Tumusiime (B. STAT, MSc.CEB (Candid.)), tcathbert1{at}gmail.com; Achilles Katamba (MBChB, DCH, MS, PhD), amkatamba{at}gmail.com; Lydia Nakiyingi (MBChB, MMED (Internal Medicine), PhD, FRCP (Edin)), lydiakiyingi{at}gmail.com; Joan Kalyango (B. Pharm, MSc. Pharm, MSc, PhD), nakayaga2001{at}yahoo.com
Data Availability
The datasets of the study are available on reasonable request from the corresponding author.
List of abbreviations
- AIDS
- Acquired Immunodeficiency Syndrome
- aRR
- Adjusted Risk Ratio
- ART
- Anti-Retroviral Treatment
- BC
- PTB Bacteriologically Confirmed Pulmonary Tuberculosis
- BMI
- Body Mass Index
- CBD
- Central Business District
- CD
- PTB Clinically Diagnosed Pulmonary Tuberculosis
- CDC
- Centers for Disease Control and Prevention
- CHS
- College of Health Sciences
- CI
- Confidence Interval
- COVID-19
- Corona Virus Disease Nineteen
- cRR
- Crude Risk Ratio
- DM
- Diabetes Mellitus
- DOT
- Directly Observed Treatment
- DTU
- Diagnosis and Treatment Unit
- HIV
- Human Immunodeficiency Virus
- HMIS
- Health Management Information System
- HSDP
- Health Sector Development Plan
- INH
- Isoniazid
- IRB
- Institutional Review Board
- KCCA
- Kampala Capital City Authority
- LTF
- Loss to Follow-up
- MDR-TB
- Multi-Drug Resistant Tuberculosis
- MOH
- Ministry of Health
- MUAC
- Mid-Upper Arm Circumference
- NTLP
- National Tuberculosis & Leprosy Control Programme
- PTB
- Pulmonary Tuberculosis
- SDGs
- Sustainable Development Goals
- SOMREC
- School of Medicine Research Ethics Committee
- TSR
- Treatment Success Rate
- UN
- United nations
- WHO
- World Health Organization